- Home
- ARDX vs CSR Comparison
ARDX vs CSR Comparison
Compare ARDX & CSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARDX
- CSR
- Stock Information
- Founded
- ARDX 2007
- CSR 1970
- Country
- ARDX United States
- CSR United States
- Employees
- ARDX N/A
- CSR N/A
- Industry
- ARDX Biotechnology: Pharmaceutical Preparations
- CSR Real Estate Investment Trusts
- Sector
- ARDX Health Care
- CSR Real Estate
- Exchange
- ARDX Nasdaq
- CSR Nasdaq
- Market Cap
- ARDX 882.9M
- CSR 982.6M
- IPO Year
- ARDX 2014
- CSR N/A
- Fundamental
- Price
- ARDX $5.55
- CSR $58.71
- Analyst Decision
- ARDX Strong Buy
- CSR Buy
- Analyst Count
- ARDX 9
- CSR 7
- Target Price
- ARDX $10.50
- CSR $70.00
- AVG Volume (30 Days)
- ARDX 3.1M
- CSR 108.0K
- Earning Date
- ARDX 10-30-2025
- CSR 10-27-2025
- Dividend Yield
- ARDX N/A
- CSR 5.37%
- EPS Growth
- ARDX N/A
- CSR N/A
- EPS
- ARDX N/A
- CSR N/A
- Revenue
- ARDX $386,146,000.00
- CSR $267,076,000.00
- Revenue This Year
- ARDX $17.79
- CSR $5.34
- Revenue Next Year
- ARDX $27.82
- CSR $2.80
- P/E Ratio
- ARDX N/A
- CSR N/A
- Revenue Growth
- ARDX 83.88
- CSR 3.44
- 52 Week Low
- ARDX $3.21
- CSR $52.76
- 52 Week High
- ARDX $7.04
- CSR $75.92
- Technical
- Relative Strength Index (RSI)
- ARDX 34.81
- CSR 52.35
- Support Level
- ARDX $5.49
- CSR $57.62
- Resistance Level
- ARDX $6.78
- CSR $59.03
- Average True Range (ATR)
- ARDX 0.21
- CSR 1.31
- MACD
- ARDX -0.15
- CSR -0.07
- Stochastic Oscillator
- ARDX 5.02
- CSR 67.83
About ARDX Ardelyx Inc.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
About CSR D/B/A Centerspace
Centerspace is a real estate investment trust (REIT) that focuses on the ownership, management, acquisitions, redevelopment, and development of apartment communities. The company operates through a single reportable segment which includes the ownership, management, development, redevelopment, and acquisition of apartment communities and conduct their corporate operations from offices in Minot, North Dakota and Minneapolis, Minnesota.